Cellular circadian period
2 papers5 findings
- Humans2
Associations
5p-Tau217
upin humans1
1 study
p-Tau217
upin humans1
Cellular circadian period is associated with p-Tau217 in humans.
“A longer intrinsic circadian period was selectively associated with higher pTau-217, NfL, and GFAP levels and medial temporal atrophy”
Humansin older adults with cognitive complaintsn = 135
Proceedings of the National Academy of Sciences of the United States of America2 Mar 2026
Clinical decline
upin humans1HR 4.41
1 study
Clinical decline
upin humans1HR 4.41
Cellular circadian period predicts clinical decline in humans (HR = 4.41, 95% CI: 1.52 to 12.83).
“Both longer period (HR = 4.41, 95% CI: 1.52 to 12.83) and greater Δ-period (HR = 2.65, 95% CI: 1.03 to 6.86) independently predicted faster clinical decline.”
Humansin older adults with cognitive complaintsn = 135
Proceedings of the National Academy of Sciences of the United States of America2 Mar 2026
NfL
upin humans1
1 study
NfL
upin humans1
Cellular circadian period is associated with NfL in humans (p <0.001).
“neural injury and degeneration (plasma NfL, p <0.001, large effect size; MRI Schelten's scale, p = 0.033, small effect size)”
Humansolder adults with cognitive complaintsn = 135
AAIC 2025 abstract23 Dec 2025
pTau-217
upin humans1
1 study
pTau-217
upin humans1
Cellular circadian period is associated with pTau-217 in humans (p = 0.012).
“The cellular circadian period was significantly associated with tau proteinopathy (plasma pTau‐217, p = 0.012, small effect size)”
Humansolder adults with cognitive complaintsn = 135
AAIC 2025 abstract23 Dec 2025
Clinical progression
upin humans1HR 3.59
1 study
Clinical progression
upin humans1HR 3.59
Cellular circadian period raises the risk of clinical progression in humans (HR=3.59, p = 0.01).
“Survival analysis showed that longer cellular circadian period were associated with faster clinical progression (HR=3.59, p = 0.01).”
Humansolder adults with cognitive complaintsn = 135
AAIC 2025 abstract23 Dec 2025